CEO of Johnson & Johnson Says Crucial Coronavirus Vaccine Data Will Come Next Week
The world is days away from getting crucial results on one of the most important coronavirus vaccines in development.
Johnson & Johnson CEO Alex Gorsky said Tuesday the healthcare giant will have results from a 45,000-person study testing its single-dose COVID-19 vaccine by early next week.
“We look forward to sharing further details of our Phase 3 study by early next week,” Gorsky said on a Tuesday morning earnings call.
The company had previously stated it expected a readout by the end of January. The new timeline allows for a modest delay, with the possibility that results won’t come until the first days of February.
If successful, J&J will still need to apply for and receive emergency authorization from US regulators. That process took just under three weeks for the two previously authorized vaccines, meaning J&J’s vaccine could be OK’d in late-February and start to be rolled out in March.
